MARKET

SESN

Sesen Bio, Inc.
SESN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.6308
16.32
4.166
661,349,656.50
Based on the provided financial report articles, the title of the article is: "Carisma Therapeutics Inc. (Form 10-K)
Press release · 4d ago
Carisma Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/31 23:04
CARISMA THERAPEUTICS INC: HAS PAUSED ALL RESEARCH AND DEVELOPMENT ACTIVITIES AT THIS TIME, PENDING OUTCOME OF REVIEW
Reuters · 03/31 20:30
CARISMA THERAPEUTICS INC: ON DEC 24, APPOINTS NATALIE MCANDREW AS PRINCIPAL FINANCIAL OFFICER
Reuters · 12/26/2024 21:04
CARISMA THERAPEUTICS INC <CARM.O>: BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1 FROM $10
Reuters · 12/12/2024 06:13
CARISMA THERAPEUTICS INC <CARM.O>: BTIG CUTS TO NEUTRAL FROM BUY
Reuters · 12/10/2024 08:31
CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31
Reuters · 12/09/2024 13:30
CARISMA THERAPEUTICS, INC. <CARM.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $5 FROM $8
Reuters · 11/25/2024 11:12
More

Webull offers Sesen Bio, Inc. stock information, including NASDAQ: SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SESN stock methods without spending real money on the virtual paper trading platform.